Zusammenfassung
Die rasante Entwicklung neuer, spezifischer Medikamente in der Krebsmedizin führt zu einer Zunahme sowohl chronisch kranker onkologischer Patienten als auch hämatologischer Patienten, die trotz signifikanter Komorbiditäten und höheren Alters zunehmend aggressiv behandelt werden. Deshalb wird es mittelfristig zu einer Zunahme an hämatolgischen und onkologischen Notfallpatienten kommen, die multidisziplinär und kompetent versorgt werden müssen. Der Übersichtsartikel stellt einen Leitfaden für das Management einiger häufiger Krankheitsbildern dar.
Abstract
The rapid development of novel, targeted drugs in cancer medicine has led to an increase in chronically ill cancer patients and hematology patients, who are being treated aggressively despite significant comorbidities and higher age. This development will lead to an increase in the number of hematologic and oncologic emergencies, and these patients will be seen by various specialties. This review article, therefore, aims at providing clinical management algorithms for the most frequent emergencies.
This is a preview of subscription content, log in via an institution to check access.
Literatur
Behl D, Hendrickson AW, Moynihan TJ (2010) Oncologic emergencies. Crit Care Clin 26(1):181–205
Esposito P, Piotti G, Bianzina S et al (2011) The syndrome of inappropriate antidiuresis: pathophysiology, clinical management and new therapeutic options. Nephron Clin Pract 119(1):c62–73 (discussion c73)
Schrier RW, Gross P, Gheorghiade M et al (2006) Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 355(20):2099–2112
Lee CT, Yang CC, Lam KK et al (2006) Hypercalcemia in the emergency department. Am J Med Sci 331(3):119–123
McCurdy MT, Shanholtz CB (2012) Oncologic emergencies. Crit Care Med 40(7):2212–2222
Coiffier B, Altman A, Pui CH et al (2008) Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol 26(16):2767–2778
Cairo MS, Coiffier B, Reiter A, Younes A (2010) Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haematol 149(4):578–586
Wilson LD, Detterbeck FC, Yahalom J (2007) Clinical practice. Superior vena cava syndrome with malignant causes. N Engl J Med 356(18):1862–1869
Lepper PM, Ott SR, Hoppe H et al (2009) Superior vena cava syndrome in thoracic malignancies. Respir Care 56(5):653–666
Peacock KH, Lesser GJ (2006) Current therapeutic approaches in patients with brain metastases. Curr Treat Options Oncol 7(6):479–489
Sirven JI, Wingerchuk DM, Drazkowski JF et al (2004) Seizure prophylaxis in patients with brain tumors: a meta-analysis. Mayo Clin Proc 79(12):1489–1494
Tosoni A, Ermani M, Brandes AA (2004) The pathogenesis and treatment of brain metastases: a comprehensive review. Crit Rev Oncol Hematol 52(3):199–215
Interessenkonflikt
Der korrespondierende Autor gibt für sich und seine Koautoren an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
von Bergwelt-Baildon, M., Böll, B., Shimabukuro-Vornhagen, A. et al. Hämatologische und onkologische Notfälle. Med Klin Intensivmed Notfmed 108, 184–190 (2013). https://doi.org/10.1007/s00063-012-0176-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00063-012-0176-0